UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation

European journal of clinical pharmacology, 2019-06, Vol.75 (6), p.831-836

2019

Volltextzugriff (PDF)

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine

International journal of infectious diseases, 2021-02, Vol.103, p.402-403

2021

Volltextzugriff (PDF)

De-simplifying antiretroviral therapy from a single-tablet to a two-tablet regimen: Acceptance, patient-reported outcomes, and cost savings in a multicentre study

HIV medicine, 2024-05, Vol.25 (9), p.1019-1029

2024

Volltextzugriff (PDF)

Pharmacokinetics of the combination raltegravir/atazanavir in HIV‐1‐infected patients

HIV medicine, 2013-08, Vol.14 (7), p.449-452

2013

Volltextzugriff (PDF)

Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment

Netherlands journal of medicine, 2008-05, Vol.66 (5), p.185-190

2008

Volltextzugriff (PDF)

025 Immunological changes in atopic dermatitis patients treated with different dosing intervals of dupilumab

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S185-S185

2022

Volltextzugriff (PDF)

EPS6.08 Cystic fibrosis elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using Tacrolimus, a drug-drug interaction study

Journal of cystic fibrosis, 2023-06, Vol.22, p.S54-S55

2023

Volltextzugriff (PDF)

093 Tear fluid dupilumab levels of patients with moderate-to-severe atopic dermatitis and ocular surface disease

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S196-S196

2022

Volltextzugriff (PDF)

Efavirenz dose reduction is safe in patients with high plasma concentrations and may prevent efavirenz discontinuations

Journal of acquired immune deficiency syndromes (1999), 2009-10, Vol.52 (2), p.240-245

2009

Volltextzugriff (PDF)

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir

AIDS (London), 2010-05, Vol.24 (8), p.1223-1226

2010

Volltextzugriff (PDF)

Relating protease inhibitor resistance at time of virological failure with drug exposure

Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.P118-P118

2010

Volltextzugriff (PDF)

N797 Therapeutic drug monitoring after thiopurine initiation improves drug efficacy

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S489-S490

2017

Volltextzugriff (PDF)

Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers

Journal of antimicrobial chemotherapy, 2010-10, Vol.65 (10), p.2188-2194

2010

Volltextzugriff (PDF)

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study

Antiviral therapy, 2009, Vol.14 (1), p.75-83

2009

Volltextzugriff (PDF)

Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin

AIDS (London), 2009-03, Vol.23 (6), p.742-744

2009

Volltextzugriff (PDF)

Metformin-associated lactic acidosis: an insufficiently recognised problem

Nederlands tijdschrift voor geneeskunde, 2017, Vol.161, p.D1823

2017

Volltextzugriff (PDF)

Drug-drug interactions between raltegravir and pravastatin in healthy volunteers

Journal of acquired immune deficiency syndromes (1999), 2010-09, Vol.55 (1), p.82-86

2010

Volltextzugriff (PDF)

Acute caffeine intoxication after intake of 'herbal energy capsules'

Nederlands tijdschrift voor geneeskunde, 2008-07, Vol.152 (28), p.1583

2008

Volltextzugriff (PDF)

Epstein-Barr virus in a CD8-positive T-cell lymphoma

The American journal of pathology, 1990-05, Vol.136 (5), p.1093-1099

1990

Volltextzugriff (PDF)

Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy

Clinical and experimental allergy, 2024-04, Vol.54 (4), p.241-252

2024

Volltextzugriff (PDF)

First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020

PloS one, 2024-07, Vol.19 (7), p.e0307963

2024

Volltextzugriff (PDF)

Busulfan Interlaboratory Proficiency Testing Program Revealed Worldwide Errors in Drug Quantitation and Dose Recommendations

Therapeutic drug monitoring, 2023-12, Vol.45 (6), p.760

2023

Volltextzugriff (PDF)

Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen

AIDS (London), 2024-07, Vol.38 (8), p.1257-1262

2024

Volltextzugriff (PDF)

Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab

Journal of investigative dermatology, 2023-09, Vol.143 (9), p.1822-1825.e3

2023

Volltextzugriff (PDF)

Estimate of traffic energy consumption from vehicle fleet distribution forecast

E3S web of conferences, 2019, Vol.116, p.46

2019

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(47)
Niederländisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine

De-simplifying antiretroviral therapy from a single-tablet to a two-tablet regimen: Acceptance, patient-reported outcomes, and cost savings in a multicentre study

Pharmacokinetics of the combination raltegravir/atazanavir in HIV‐1‐infected patients

Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment

025 Immunological changes in atopic dermatitis patients treated with different dosing intervals of dupilumab

EPS6.08 Cystic fibrosis elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using Tacrolimus, a drug-drug interaction study

093 Tear fluid dupilumab levels of patients with moderate-to-severe atopic dermatitis and ocular surface disease

Efavirenz dose reduction is safe in patients with high plasma concentrations and may prevent efavirenz discontinuations

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir

Relating protease inhibitor resistance at time of virological failure with drug exposure

N797 Therapeutic drug monitoring after thiopurine initiation improves drug efficacy

Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study

Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin

Metformin-associated lactic acidosis: an insufficiently recognised problem

Drug-drug interactions between raltegravir and pravastatin in healthy volunteers

Acute caffeine intoxication after intake of 'herbal energy capsules'

Epstein-Barr virus in a CD8-positive T-cell lymphoma

Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy

First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020

Busulfan Interlaboratory Proficiency Testing Program Revealed Worldwide Errors in Drug Quantitation and Dose Recommendations

Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen

Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab

Estimate of traffic energy consumption from vehicle fleet distribution forecast

Suchergebnisse filtern